| 000 | 01764 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515044153.0 | ||
| 264 | 0 | _c20070212 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a0165-1781 | ||
| 024 | 7 |
_a10.1016/j.pscychresns.2006.02.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCatafau, Ana M | |
| 245 | 0 | 0 |
_aDopamine D2 receptor occupancy by risperidone: implications for the timing and magnitude of clinical response. _h[electronic resource] |
| 260 |
_bPsychiatry research _cDec 2006 |
||
| 300 |
_a175-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aBrief Psychiatric Rating Scale |
| 650 | 0 | 4 |
_aCorpus Striatum _xdiagnostic imaging |
| 650 | 0 | 4 |
_aDominance, Cerebral _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrontal Lobe _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOccipital Lobe _xdiagnostic imaging |
| 650 | 0 | 4 |
_aPsychotic Disorders _xblood |
| 650 | 0 | 4 | _aPyrrolidines |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xmetabolism |
| 650 | 0 | 4 |
_aRisperidone _xpharmacokinetics |
| 650 | 0 | 4 |
_aSchizophrenia _xblood |
| 650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCorripio, Iluminada | |
| 700 | 1 | _aPérez, Victor | |
| 700 | 1 | _aMartin, Juan Carlos | |
| 700 | 1 | _aSchotte, Alain | |
| 700 | 1 | _aCarrió, Ignasi | |
| 700 | 1 | _aAlvarez, Enric | |
| 773 | 0 |
_tPsychiatry research _gvol. 148 _gno. 2-3 _gp. 175-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pscychresns.2006.02.001 _zAvailable from publisher's website |
| 999 |
_c16634791 _d16634791 |
||